We are live on ! Find out more
IVF

INVO Fertility Inc

6 hedge funds and large institutions have $197K invested in INVO Fertility Inc in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

2.01% more ownership

Funds ownership: 0.18%2.19% (+2%)

19% less capital invested

Capital invested by funds: $242K → $197K (-$45K)

25% less funds holding

Funds holding: 86 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
6
Holders Change
-2
Holders Change %
-25%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
1
Closed
5
Calls
Puts
Net Calls
Net Calls Change

IVF Hedge Fund Activity: Q4 2025 in Review

6 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in INVO Fertility Inc (IVF) for Q4 2025, worth a combined $197K — down 19% from $242K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of IVF and 3 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $724K. The largest seller was DRW Securities, exiting entirely with an estimated $133K sold.

  • 6 institutional investors held INVO Fertility Inc (IVF) as of Q4 2025, down from 8 in Q3 2025.
  • Funds reported $197K of INVO Fertility Inc stock for Q4 2025, down 19% quarter-over-quarter.
  • 3 funds opened new INVO Fertility Inc positions in Q4 2025 and 5 closed out, a net change of -2 holders.
  • The largest INVO Fertility Inc buyer in Q4 2025 was Armistice Capital, an estimated $724K added.
  • The largest INVO Fertility Inc seller in Q4 2025 was DRW Securities, an estimated $133K sold.

Based on aggregated 13F filings for Q4 2025.